SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001640334-21-000373
Filing Date
2021-02-17
Accepted
2021-02-17 16:59:40
Documents
1
Period of Report
2021-02-12

Document Format Files

Seq Description Document Type Size
1 FORM 4 form4.html 4  
1 FORM 4 form4.xml 4 4352
  Complete submission text file 0001640334-21-000373.txt   5925
Mailing Address C/O INNOVIVE PHARMACEUTICALS, INC. 555 MADISON AVENUE, 25TH FLOOR NEW YORK NY 10022
Business Address
Kelly Steven (Reporting) CIK: 0001339478 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38951 | Film No.: 21645780

Mailing Address 888 PROSPECT STREET, SUITE 210 LA JOLLA CA 92037
Business Address 888 PROSPECT STREET, SUITE 210 LA JOLLA CA 92037 760-943-1689
ARTELO BIOSCIENCES, INC. (Issuer) CIK: 0001621221 (see all company filings)

IRS No.: 331220924 | State of Incorp.: NV | Fiscal Year End: 0831
SIC: 2834 Pharmaceutical Preparations